Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Total Debt (2016 - 2022)

Acro Biomedical (ACBM) has 7 years of Total Debt data on record, last reported at $157652.0 in Q4 2022.

  • For Q4 2022, Total Debt rose 280.05% year-over-year to $157652.0; the TTM value through Dec 2022 reached $157652.0, up 280.05%, while the annual FY2022 figure was $157652.0, 280.05% up from the prior year.
  • Total Debt reached $157652.0 in Q4 2022 per ACBM's latest filing, up from $78594.0 in the prior quarter.
  • Across five years, Total Debt topped out at $485902.0 in Q4 2020 and bottomed at $3266.0 in Q4 2018.
  • Average Total Debt over 5 years is $103131.0, with a median of $70306.0 recorded in 2020.
  • Peak YoY movement for Total Debt: tumbled 92.11% in 2018, then soared 1749.01% in 2020.
  • A 5-year view of Total Debt shows it stood at $3266.0 in 2018, then surged by 704.62% to $26279.0 in 2019, then skyrocketed by 1749.01% to $485902.0 in 2020, then tumbled by 91.46% to $41482.0 in 2021, then surged by 280.05% to $157652.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Total Debt were $157652.0 in Q4 2022, $78594.0 in Q3 2022, and $21245.0 in Q2 2022.